TrialInternational ophthalmology2025

Netarsudil v/s Ripasudil: The battle of supremacy between two ROCKS-I (rho kinase inhibitors).

Riddhima Juneja et al.PubMed ↗Publisher ↗

No numbers read from the abstract.